Word

ELEVECTA

Status

Registered

Status Code

700

Status Date

Tuesday, July 28, 2020

Serial Number

79272524

Registration Number

6110170

Registration Date

Tuesday, July 28, 2020

Mark Type

4

Filing Date

Monday, August 12, 2019

Published for Opposition

Tuesday, May 12, 2020

Trademark Owner History

CEVEC Pharmaceuticals GmbH - Original Registrant

Classifications

5 Medicines for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; pharmaceutical and veterinary products, preparations and reagents for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; chemical, biological and biochemical substances, preparations and reagents for medical and veterinary purposes, namely, for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; diagnostic and analytical preparations for medical and veterinary purposes; cultures of microorganisms and viruses for medical or veterinary purposes, in particular adeno-associated viruses; proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for medical or veterinary purposes, namely, for the treatment of leukemia, of solid and liquid cancer, of monogenic diseases, of neurological disorders, of neuromuscular disorders, of metabolic disorders, and of viral and infectious diseases; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing stable or transient transfected eukaryotic cell lines and eukaryotic cells, for medical and veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing viral vectors, in particular vectors of adeno-associated viruses, for medical, veterinary and medical diagnostic purposes

1 Chemical, biological and biochemical reagents for scientific, research, laboratory, industrial and commercial purposes; Chemical, biological and biochemical substances and preparations for scientific, research and laboratory use; chemical, biological and biochemical substances, preparations and reagents for research use in characterizing diseases; chemical, biological and biochemical substances, preparations and reagents for scientific and medical research and drug development; chemical, biological and biochemical substances, preparations and reagents for manufacturing drugs and pharmaceuticals; cultures of microorganisms and viruses, other than for medical or veterinary purposes, in particular adeno-associated viruses; proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells, other than for medical or veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells, for manufacturing stable or transient transfected eukaryotic cell lines and eukaryotic cells, other than for medical or veterinary purposes; expression systems in the nature of microorganisms, insect cells, and mammalian cells for scientific, research, laboratory, industrial and commercial purposes, namely, for manufacturing viral vectors, in particular vectors of adeno-associated viruses

42 Scientific and industrial research, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures, and expression systems in the nature of microorganisms, insect cells, and mammalian cells; scientific, technical and industrial research consultancy, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific laboratory services, namely, cultivation, extraction, optimization, synthesizing and modifying of eukaryotic cell lines, eukaryotic cells, in particular transfecting and selecting of eukaryotic cells and eukaryotic cell lines with a nucleic acid, in particular a plasmid, viruses, in particular adeno-associated viruses, viral vectors, in particular vectors of adeno-associated viruses, polypeptides, proteins, nucleotides, nucleic acids, for third parties for scientific, research, laboratory, development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific analysis, research and development in the nature of analysis and selection of transfected eukaryotic cells and eukaryotic cell lines and viral vectors, in particular vectors of adeno-associated viruses, for third parties for scientific, research, laboratory, development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics

Trademark Events

Nov 26, 2019

Assigned To Examiner

Nov 21, 2019

Sn Assigned For Sect 66a Appl From Ib

Nov 25, 2019

New Application Office Supplied Data Entered

Dec 3, 2019

Non-Final Action Written

Nov 29, 2019

Application Filing Receipt Mailed

Dec 4, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Jan 2, 2020

Refusal Processed By Mpu

Jan 3, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Jan 24, 2020

Refusal Processed By Ib

Mar 17, 2020

Correspondence Received In Law Office

Mar 17, 2020

Teas Response To Office Action Received

Mar 18, 2020

Teas/Email Correspondence Entered

Apr 1, 2020

Approved For Pub - Principal Register

Apr 22, 2020

Notification Of Notice Of Publication E-Mailed

May 12, 2020

Published For Opposition

May 12, 2020

Official Gazette Publication Confirmation E-Mailed

Jul 28, 2020

Registered-Principal Register

Jun 11, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 11, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Jun 11, 2021

Teas Change Of Correspondence Received

Oct 28, 2020

Final Disposition Notice Created, To Be Sent To Ib

Nov 16, 2020

Final Disposition Processed

Nov 17, 2020

Final Disposition Notice Sent To Ib

Dec 6, 2020

Final Decision Transaction Processed By Ib

Jun 11, 2021

Teas Change Of Domestic Representatives Address

Jul 13, 2021

Teas Change Of Correspondence Received

Aug 21, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 21, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 21, 2023

Teas Withdrawal As Domestic Representative Received

Aug 21, 2023

Teas Change Of Owner Address Received

Aug 21, 2023

Teas Change Of Domestic Representatives Address

Aug 21, 2023

Teas Change Of Correspondence Received

Nov 19, 2023

New Representative At Ib Received

Aug 9, 2024

Teas Change Of Owner Address Received

Aug 9, 2024

Teas Change Of Domestic Representatives Address

Aug 9, 2024

Applicant/Correspondence Changes (Non-Responsive) Entered

Aug 9, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 9, 2024

Teas Change Of Correspondence Received

Aug 9, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 21, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 13, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 13, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 13, 2021

Teas Change Of Domestic Representatives Address